Anheuser-Busch InBev (BUD) Posts Solid Q2 Results but China Weakness Sends Shares Down 2%
Key Takeaways
- Revenue and EPS beat estimates: Anheuser-Busch InBev reported Q2 2026 revenue of $16.66 billion (up 5.6% organically) and underlying earnings per share of $1.21, topping consensus estimates of $16.39 billion and $1.12 respectively.
- Beer volumes returned to growth: Global beer volumes rose 1.1% in the quarter, marking a continuation of positive momentum, while total volumes increased 0.9% year over year.
- Megabrands and Beyond Beer drove outperformance: Combined revenue from megabrands grew 6.2%, led by Corona (up 17% outside its home market), while Beyond Beer revenue surged 44% and no-alcohol beer climbed 27%.
- China remained a significant drag: China volumes fell 9.7% in the quarter, driven by adverse weather and persistent weakness in on-premise channels, weighing on investor sentiment.
- Stock declined despite the beat: BUD shares fell roughly 2% on July 30 as the China headwinds overshadowed an otherwise strong set of global results.
- Full-year guidance reaffirmed: Management reiterated its fiscal 2026 EBITDA (earnings before interest, taxes, depreciation, and amortization) growth outlook of 4% to 8%.
Why These Earnings Matter
Anheuser-Busch InBev, the world's largest brewer and owner of iconic brands such as Budweiser, Corona, Stella Artois, and Michelob Ultra, delivered its second-quarter 2026 results against a backdrop of uneven global consumer demand. This earnings report carried heightened significance for several reasons: it was the first full quarter to capture the demand uplift from the FIFA World Cup, it provided a reading on whether recent volume stabilization could translate into sustained growth, and it offered a critical update on the company's premiumization and digital transformation strategy. Coming off a strong Q1 in which BUD also exceeded expectations, investors closely watched whether the brewer could maintain momentum across its diverse geographic portfolio, particularly as macroeconomic headwinds persisted in key markets. The results ultimately confirmed the company's operational strength globally while exposing ongoing challenges in China. I also checked comparable names in the sector using Tickeron’s AI Screener to put the results in context.
The Quarter in Detail
For the second quarter ended June 30, 2026, AB InBev reported organic revenue growth of 5.6% to $16.66 billion, comfortably exceeding the analyst consensus estimate of approximately $16.34–$16.39 billion. On a reported basis, revenue increased 11.0%, benefiting from favorable currency translation effects. Revenue per hectoliter rose 4.2%, reflecting disciplined revenue management and a favorable product mix shift toward premium brands.
Underlying earnings per share (EPS) surged 23.4% year over year to $1.21, beating consensus estimates of $1.12 by $0.09. Underlying profit attributable to equity holders reached $2.39 billion, up from $1.95 billion in the same quarter last year. On a reported basis, profit attributable to equity holders jumped to $3.75 billion from $1.68 billion in the prior-year period, supported by non-underlying items.
Normalized EBITDA grew 5.8% to $5.94 billion, with the EBITDA margin expanding 4 basis points to 35.6%, even as the company increased sales and marketing investments. Free cash flow for the first half of 2026 improved dramatically, rising by $2.53 billion to $3.88 billion, reflecting stronger operating profit and improved working capital management. The company's net debt-to-normalized EBITDA ratio improved to 2.86x from 3.27x a year earlier.
Beer volumes returned to growth at 1.1%, while total volumes — including non-beer products — rose 0.9%. Performance was broad-based across four of the company's five geographic zones, with standout results in Middle Americas and South America. The North America segment posted a 2.7% revenue increase, driven by Michelob Ultra, Busch Light, and the Beyond Beer portfolio. However, the Asia Pacific region underperformed, with China volumes declining 9.7% and revenue falling 8.6%, as weak weather and subdued on-premise traffic continued to pressure the business.
Market Reaction
Despite a headline beat on both revenue and earnings, BUD shares declined roughly 2% in premarket and intraday trading on July 30, reflecting a clear tension between the company's global strength and the persistent weakness in its Chinese operations. The stock, which had climbed approximately 33.7% year-to-date and was trading near its 52-week high of $85.56 heading into the report, faced selling pressure as investors digested the magnitude of the China slowdown. AB InBev's Asia Pacific subsidiary, Budweiser APAC, reported that China volumes fell 9.7% and revenue dropped 8.6% in the second quarter, with management acknowledging that more work is needed to stabilize that market. This overshadowed otherwise solid results from Latin America, Europe, and North America. The market's reaction underscores how elevated expectations and the concentrated nature of China's headwinds can weigh on sentiment, even when the broader business is performing well. From what I see, the premiumization trends remain a bright spot worth monitoring closely.
Forward Outlook and What I’m Watching
Management reaffirmed its full-year 2026 EBITDA growth guidance of 4% to 8%, signaling confidence that the underlying business momentum can absorb near-term pressures. The company expects growth to be more evenly balanced between the first and second halves of the year, supported in part by transactional foreign exchange effects that are projected to turn from headwinds into tailwinds, particularly in Mexico and Brazil.
Several factors will be critical for investors to monitor in the months ahead. First, the trajectory of the Chinese market remains the most significant wild card. Management has indicated that the on-premise channel has shown no meaningful improvement through July, and channel inventory levels may continue to decline modestly in the second half. Any stabilization or recovery in China would be a powerful catalyst for sentiment, while further deterioration could continue to weigh on the stock.
Second, the company's premiumization strategy continues to deliver results, with megabrands, no-alcohol beer, and Beyond Beer all posting double-digit growth. The sustained double-digit expansion of Corona, Stella Artois, and Michelob Ultra outside their home markets underscores the global appeal of AB InBev's brand portfolio. Third, the digital ecosystem — particularly the BEES B2B (business-to-business) marketplace, which saw gross merchandise value rise 50% to $1.2 billion — represents a growing source of efficiency and revenue diversification that deserves continued attention.
On the cost side, management flagged potential pressure from unhedged energy and logistics costs in the second half, though disciplined revenue management and premiumization are expected to provide partial offsets. The company's $6 billion share buyback program, of which $1.9 billion had been completed as of July 24, also provides a structural support element for the stock. Lastly, capital expenditures are projected to remain within the $3.5 billion to $4 billion range for the full year, while the normalized effective tax rate is expected to land between 26% and 28%.
Enhancing Research with Tickeron Tools
In my own process, I often turn to Tickeron’s AI Screener when evaluating earnings reports like this one. It helps quickly filter peers by fundamentals, volume trends, and technical signals so I can see how BUD stacks up without spending hours on manual screens. The tool surfaces ideas that align with specific criteria, which I find useful during busy earnings seasons.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
BUD's RSI Indicator recovers from oversold territory
The RSI Indicator for BUD moved out of oversold territory on October 05, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In 16 of the 23 cases the stock moved higher. This puts the odds of a move higher at 70%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where BUD advanced for three days, in 186 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
BUD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BUD as a result. In 38 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 49%.
The Moving Average Convergence Divergence Histogram (MACD) for BUD turned negative on September 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 21 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 49%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BUD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating for company is 32 (best 1 - 100 worst), which means the company is slightly undervalued. The valuation of the company is based on a proprietary formula which takes into account a set of fundamentals and gives us an estimate of the price per share for the company. We then compare this estimate with the current price per share. As a result, this company is rated as undervalued in the industry. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.624) is normal, around the industry mean (2.040). P/E Ratio (16.616) is within average values for comparable stocks, (16.716). Projected Growth (PEG Ratio) (1.583) is also within normal values, averaging (2.082). Dividend Yield (0.018) settles around the average of (0.034) among similar stocks. BUD's P/S Ratio (2.564) is slightly higher than the industry average of (1.539).
The Tickeron PE Growth Rating for this company is 40 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 50 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. BUD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a holding company whose subsidiaries manufactures and distributes alcoholic and non-alcoholic beverages
Industry FoodMeatFishDairy
Advertisement